CellVax Therapeutics, Inc. logo

CellVax Therapeutics, Inc. jobs and careers

United States

About CellVax Therapeutics, Inc.

CellVax Therapeutics is a privately-held clinical-stage company active in research, development, and innovation on individualized cell-based immunotherapies. CellVax Therapeutics has developed a proprietary personalized tumor cell-based cancer immuno-therapy platform. The company has completed Phase I and Phase II clinical trial in Brazil and has initiated (Oct 24) a Phase II Adaptive Design Trial for patients with high-risk prostate cancer. https://clinicaltrials.gov/study/NCT06636682

Founded in 2020 by Fernando Kreutz.

Founded
2020
Employees
1 to 10
Total funding
$5.2M
Headquarters
United States

Leadership

The top of CellVax Therapeutics, Inc.'s org chart, with how many people report into each leader.

EGPhoto of Emerson von der Goltz

Emerson von der Goltz

Chief Financial Officer